Orthopediatrics KIDS
NASDAQ KIDS
$26.27 -0.23 (-0.87%)
At close: Aug 20, 2026 · 1:11 PM UTC

Orthopediatrics (KIDS) Restructuring Costs (2024 - 2026)

Orthopediatrics (KIDS) posted quarterly Restructuring Costs of $296000.0 for Q4 2025, down 91.9% year-over-year from $3.7 million in Q4 2024, and down 87.1% quarter-over-quarter from $2.3 million in Q3 2025.

Orthopediatrics (KIDS) Restructuring Costs (2024 - 2026) Analysis & Trends

Orthopediatrics (KIDS) has reported Restructuring Costs for 2 consecutive years, with $296000.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Restructuring Costs fell 91.9% year-over-year to $296000.0; the TTM figure through Mar 2026 stood at $5.6 million (up 50.58% YoY), while the FY2025 annual figure was $5.6 million, up 53.33% from the prior year.
  • Restructuring Costs declined to $296000.0 in Q4 2025 per KIDS's latest filing, from $2.3 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $3.7 million in Q4 2024 and bottomed at $40000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.24 Bn 193.64 Bn 7.27 Bn
2 Stryker 128.63 Bn 125.15 Bn 4.50 Bn
3 Medtronic 119.19 Bn 109.97 Bn 6.41 Bn
4 Boston Scientific 73.51 Bn 72.97 Bn 3.85 Bn
5 Edwards Lifesciences 52.11 Bn 47.85 Bn 1.35 Bn
6 Dexcom 34.64 Bn 32.70 Bn 830.00 Mn
7 GE HealthCare Technologies 34.01 Bn 31.90 Bn 2.18 Bn
8 Koninklijke Philips 26.40 Bn 23.08 Bn 4.55 Bn
9 Steris 23.14 Bn 22.65 Bn 684.20 Mn
10 Orthopediatrics 631.76 Mn 585.88 Mn 52.37 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1,000.00
Dec 31, 2025 296,000.00
Sep 30, 2025 2.29 Mn
Jun 30, 2025 2.97 Mn
Mar 31, 2025 40,000.00
Dec 31, 2024 3.65 Mn